Week Eight Predicts Six Month GLP-1 Success
A new predictive model uses early data to forecast long-term GLP-1 weight loss, exposing a massive real-world retention crisis.
August 20, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 🩺 Endocrinology.
Specialized AI Stops Fabricating Metabolic Health Metrics
Standard AI models routinely invent patient data, but a new multi-layered architecture proves we can engineer clinical accuracy.
August 14, 2026
AI insulin resistance index predicts heart disease risk
A new deep learning index predicts cardiovascular death by tracking insulin resistance in the general public, moving metabolic screening beyond diabetic patients.
August 13, 2026
Smartwatches fail to measure blood glucose levels
A rigorous new evaluation reveals that wrist-worn wearables capture no real blood glucose data, exposing a major flaw in non-invasive tracking claims.
August 5, 2026
Predicting Diabetes a Decade Before Diagnosis
Predictive algorithms can now spot type 2 diabetes risk ten years in advance, but the real bottleneck is how healthcare systems will handle millions of newly flagged patients.
July 28, 2026
AI Links Loneliness to Type Two Diabetes
A digital twin model proves that mental health is not just a quality-of-life issue but a direct driver of chronic physical disease.
July 27, 2026
AI agents beat static databases in kidney care
Adding medical guidelines to an AI does not make it a better doctor, but teaching it to argue with itself does.
July 22, 2026
Eli Lilly Bets on Oura Rings
Pharmaceutical giants are realizing that selling a weight-loss drug is only half the battle.
July 17, 2026
Telehealth GLP-1 sales bypass clinical safety
Getting a prescription for the world’s most sought-after weight-loss drugs has devolved into a frictionless, five-minute checkout process.
July 8, 2026
FDA Crackdown Hits Telehealth GLP-1 Sales
The wild west of online weight-loss drug marketing is officially coming to an end.
July 5, 2026